ST
Stock_Research_Today
Community Contributor
Followers128Total number of followers
Comments0Total number of comments
Member Since2025Date joined
Stock Research Today, provides investors with real-time market analysis, expert research, and curated financial content to support smarter, data-driven investment decisions.
No link added
Revolutionizing Cancer Treatment
A Precision Approach to Hard-to-Treat Cancers RenovoRx, Inc. (Nasdaq: RNXT), based in Mountain View, California, is a clinical-stage biopharma company taking a new approach to cancer treatment.Read more
16users have liked this narrative
3users have commented on this narrative
129users have followed this narrative
ST
US$4.2
77.1% undervalued intrinsic discount
Stock_Research_Today's Fair Value
Revenue
371.3% p.a.
Profit Margin
36%
Future PE
15x
Price in 2029
US$3.98